As Nrf1 deficiency for ~7 days to ~7 weeks corresponded with signature features of liver disease progression and this was distinct from Nrf2, we next examined their roles in protecting against MASH progression to liver tumorigenesis. The gene discussed is NFE2L2; the disease is liver disorder.